drugset / Trial / NCT00930241

Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation

NCT00930241

Phase 3 Terminated 25 enrolled Hannover Medical School
RandomizedParallel-groupOpen-labelPrevention

Summary

This study is a prospective randomized trial to compare twice daily to once daily administration of the basic immunosuppressive regimen in lung transplanted patients.

Timeline

Start
2009-07
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule

Indications

No indication recorded.